| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/30/1998 | EP0627929B1 Inhibitors of thrombosis |
| 09/30/1998 | EP0526544B1 Therapeutic uses of actin-binding compounds |
| 09/30/1998 | CN1039998C Substituted cycloalkylacetamides and its preparation, medicine and use |
| 09/30/1998 | CN1039997C Cyanoquanidines and its salt and medicinal composition containing them |
| 09/29/1998 | US5814643 Sulfonamide fibrinogen receptor antagonists |
| 09/29/1998 | US5814622 Compound useful as trypsin like serine protease as thrombin inhibitors |
| 09/29/1998 | US5814307 Synthesis of interleukins for cells |
| 09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
| 09/24/1998 | WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 09/24/1998 | WO1998041092A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 09/23/1998 | EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 09/23/1998 | EP0865281A1 Naphthyl-substituted benzimidazole derivatives as anticoagulants |
| 09/23/1998 | EP0865279A1 Hemoregulatory compounds |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193913A Compounds and pharmaceutical compositions containing them |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811548 Tri-and tetracyclic compounds |
| 09/22/1998 | US5811437 Treating cardiovascular disorder, gastrointestinal disorder, nervous system disorder related to reduced endothelial nitric oxide production |
| 09/22/1998 | US5811398 Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues |
| 09/22/1998 | US5811389 Inhibiting platelet aggregation; blood disorders |
| 09/22/1998 | US5811279 Activation of prothrombin to thrombin |
| 09/22/1998 | US5811005 Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix |
| 09/22/1998 | CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present |
| 09/17/1998 | WO1998040486A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
| 09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | WO1998040404A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040081A1 Sulfated oligosaccharides having anticoagulant/antithrombotic activity |
| 09/17/1998 | WO1998040080A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040064A1 Butyrate prodrugs derived from lactic acid |
| 09/17/1998 | WO1998031394A3 Tissue factor methods and compositions for coagulation and tumor treatment |
| 09/17/1998 | WO1998030242A3 Photochemotherapeutic compositions |
| 09/17/1998 | WO1998028282A3 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283990A1 Sulfated oligosaccharides having anticoagulant/antithrombotic activity |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2283162A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/16/1998 | EP0864561A1 Benzenesulfonylamine derivatives,process for their preparation and pharmaceutical compositions containing them |
| 09/16/1998 | EP0863918A1 Method for control of functionality during cross-linking of hemoglobins |
| 09/16/1998 | EP0863916A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 09/16/1998 | EP0863903A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 09/16/1998 | EP0863902A1 2'- 4'-HALO- 1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO CYCLOPENTANE-1,7'(8'H)- 3H]IMIDAZO 2,1-b]PURIN]-4'(5'H)-ONES |
| 09/16/1998 | EP0863893A1 Fibrinogen receptor antagonist |
| 09/16/1998 | EP0863866A1 Butyrate prodrugs of lactic acid |
| 09/16/1998 | EP0863768A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 09/16/1998 | EP0863762A1 Methods of production and use of liquid formulations of plasma proteins |
| 09/16/1998 | EP0863755A1 Antithrombotic diamines |
| 09/16/1998 | EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 09/16/1998 | EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 09/16/1998 | EP0666920B1 Thrombin activatable plasminogen derivatives |
| 09/16/1998 | EP0662841B1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 09/16/1998 | EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 09/16/1998 | EP0624095B1 Methods and compositions for reducing blood loss |
| 09/16/1998 | CN1192915A Rendu tonic wine |
| 09/15/1998 | US5808021 Method for controlling O-desulfation of heparin |
| 09/15/1998 | US5807980 Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex |
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807839 Method for stimulating red blood cell production |
| 09/15/1998 | US5807834 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807744 Incubation; separation of bone marrow and tumor cells |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/09/1998 | EP0862457A1 Infusions of neuroprotectants and thrombolytic agents |
| 09/09/1998 | EP0862454A1 Novel uses of mammalian ctla-8 and related reagents |
| 09/09/1998 | EP0715623B1 Platelet aggregation inhibitors |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192749A Peptide and compounds that bind to receptor |
| 09/09/1998 | CN1192748A Compounds and peptide that bind to the erythropoietin receptor |
| 09/09/1998 | CN1192747A Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/08/1998 | US5804571 Administering an s-omega(omega-aminoalkylamino)alkyl dihydrogen phosphorothioate |
| 09/08/1998 | US5804428 Fibrin sealant compositions and methods for utilizing same |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/08/1998 | US5804181 Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders |
| 09/08/1998 | CA2083475C Derivatives of ethanolamine, their preparation, and the pharmaceutical compositions containing them |
| 09/03/1998 | WO1998038318A1 Factor x deletion mutants and analogues thereof |
| 09/03/1998 | WO1998038317A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | WO1998038220A1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 09/03/1998 | WO1998038219A1 Purification of von willebrand factor by cation exhcanger chromatography |
| 09/03/1998 | WO1998038218A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 09/03/1998 | CA2282728A1 Factor x deletion mutants and analogues thereof |
| 09/03/1998 | CA2282707A1 Factor x analogues with a modified protease cleavage site |
| 09/02/1998 | EP0861255A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861254A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861253A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/02/1998 | EP0861080A1 Hemoregulatory compounds |